Latest - HIV/AIDS

• Racial/Ethnic and HIV Disparities in PrEP Discontinuation A better understanding of the existing disparities in PrEP discontinuation may help identify which populations are most at risk.
  AIDS, November 21, 2019
• DAA Adherence Support for People With HCV Who Inject Drugs Might the implementation of an enhanced support program help improve adherence to DAA therapy among this sub-group of HCV patients?
  Journal of Viral Hepatitis, November 20, 2019
• Evaluation of Kidney Function in HIV Patients Receiving ART How might ART regimens including inhibitors of the tubular secretion of creatinine impact kidney function in HIV patients?
  HIV Medicine, November 19, 2019
• With Exotic Cats & Video Games, Doc Exhibits LGBTQ-Friendly Care After a devastating fire, a family practice physician creates a one-of-a-kind dream clinic where everyone is welcome.
  Medscape Medical News, November 18, 2019
• Time to Rethink Renal Dosing of Lamivudine?   Dose reductions of lamivudine may not be necessary for all patients with mild to moderate renal impairment, says Dr Paul Sax.
  Medscape HIV/AIDS, November 18, 2019
• Tesamorelin Resolves NAFLD in Some HIV Patients Tesamorelin can reduce liver fat and prevent fibrosis progression in HIV patients with non-alcoholic fatty liver disease (NAFLD), according to a new phase-2 trial.
  Reuters Health Information, November 14, 2019
• EACS 2019New HIV Care Models, Apps Emerging as Patients Age Innovations include combining metabolic focus with HIV, centralizing a care team to treat patients in 90-minute appointments, and monitoring patients with mobile platforms.
  Medscape Medical News, November 15, 2019
• Nevirapine Does Not Affect Growth in HIV-Exposed Infants Prophylactic nevirapine for the prevention of mother-to-child HIV transmission was not found to negatively affect growth outcomes among uninfected infants.
  JAIDS: Journal of Acquired Immune Deficiency Syndromes, November 15, 2019
• African Children Exposed to HIV, ART Perinatally Face Higher Risk of Stunting Prolonged perinatal exposure to maternal HIV and antiretroviral therapy (ART) is associated with lower height and weight and more stunting in uninfected babies and toddlers, according to data from a study of breastfed children in Malawi and Uganda.
  Reuters Health Information, November 12, 2019
• EACS 2019Revamped HIV Guidelines Focus on Drug–Drug Interactions 'A major revision' by the European AIDS Clinical Society hones in on polypharmacy and the aging HIV population.
  Medscape Medical News, November 13, 2019
• Rapid Initiation of ART in Those With Newly Diagnosed HIV The introduction of a rapid initiation option helped shorten the time to first medical appointment and ART initiation among newly diagnosed HIV patients.
  HIV Medicine, November 12, 2019
• ANAC 2019Jitters Over New Two-Drug HIV Regimens The success of a new generation of two-drug regimens has provided an opportunity to lessen the toxic effects of lifelong HIV therapy. But the switch can be nerve-wracking for patients and clinicians.
  Medscape Medical News, November 11, 2019
• ANAC 2019Four PrEP Pills on Demand Can Stop HIV Clinics are increasing their options for pre-exposure prophylaxis (PrEP) so that people at high-risk for HIV will find it easier to prevent transmission.
  Medscape Medical News, November 08, 2019
• EACS 2019 Read clinically focused news coverage of key developments from EACS 2019
  Medscape HIV/AIDS, November 08, 2019
• EACS 2019HIV Care Shaped by Menopause as Women Age The number of women with HIV going through menopause has ballooned in the past decade, but research is lacking as clinicians navigate approaches.
  Medscape Medical News, November 08, 2019
• Alert FDA Clears Next-Gen Assay to Detect HIV-1 Drug Resistance The Sentosa SQ HIV genotyping assay is the first HIV drug resistance assay that uses next generation sequencing technology that the FDA has authorized for use.
  FDA Approvals, November 06, 2019
• DAAs for HCV During Pregnancy and Lactation Should HCV be treated with direct-acting antivirals during pregnancy? This paper summarizes current knowledge regarding the pharmacokinetics and safe use of DAAs in pregnant and breast-feeding women.
  Alimentary Pharmacology & Therapeutics, November 06, 2019
• 'Crowd Diagnosis' of STDs Popular but Often Unreliable Requests for crowd diagnoses of sexually transmitted diseases from peers on a major social media site have dramatically increased. Many of the requests are for second opinions.
  Medscape Medical News, November 05, 2019
• Post-Treatment Changes in Renal Function Among HIV Patients In what ways might these factors impact changes in renal function after HIV treatment?
  HIV Medicine, November 05, 2019
• Multidrug-Resistant Pathogens Common in MSM With Gastroenteritis Men who have sex with men (MSM) have high rates of infectious gastroenteritis, and infections with multidrug-resistant pathogens are common, according to new findings.
  Reuters Health Information, November 01, 2019